Risk Assessment Framework and Internal Controls

Why Risk Assessment Matters in Healthcare Compliance

Regulatory scrutiny is intensifying, data volumes are rising, and healthcare operations are becoming more complex. Risk assessment is no longer optional—it's essential for:

  • Ensuring compliance with ABPI, EFPIA, FCPA, GDPR, and other local/global standards
  • Protecting patient safety and product integrity
  • Safeguarding reputation, finances, and operations
  • Empowering proactive, data-driven decision-making
risk assessment in pharmaceutical industry

Our Risk Assessment Framework

Eunomia helps you move from reactive compliance to proactive governance through our structured and scalable risk management approach:

Risk Identification

We analyze your operations, third-party relationships, promotional activities, and internal processes to identify exposure points.

    Risk Assessment

    Using defined scoring models, we assess the likelihood and impact of each risk—tailored to your business model and market environment.

      Risk Response

      We recommend mitigation strategies, define control points, and create targeted action plans supported by SOPs and accountability maps.

      Risk Monitoring

      We help you track risks over time through dashboards, review cycles, and internal triggers that flag evolving compliance concerns.

      Risk Reporting & Evaluation

      We generate management-ready summaries, risk heatmaps, and audit-proof documentation to support internal reviews and external inspections.

      Challenges We Help You Overcome

      Challenge Eunomia Solution
      Local compliance complexity Risk tools and methodologies localized to country-specific regulations
      Siloed risk visibility Centralized risk dashboards and reporting structures
      Lack of actionable insights Data-driven scoring, heatmaps, and prioritized mitigation plans

      Our Capabilities

      Gap Analysis & Compliance Audits

      Centralized Risk Assessment Framework Development

      SharePoint based Risk Management Tools

      Localized and Global Risk Profiling

      Analytics for Risk Prediction & Prioritization

      transparency disclosures for pharmaceutical industry

      Why Choose Eunomia?

      • Global Perspective, Local Precision: From EU and UK frameworks to market-specific nuances, our team understands risk across borders.
      • Deep Compliance Integration: Risk frameworks grounded in EFPIA, ABPI, IFPMA, GDPR, FCPA, and national codes.
      • Not Just Advice—Real Implementation: We don’t just assess risks; we build the workflows, SOPs, and governance layers to manage them.
      • Technology-Agnostic Support: We work within your existing systems or build light tools on platforms like SharePoint.

      FAQs

      What types of risk assessments do you offer?

      We offer comprehensive compliance risk assessments across various domains—HCP engagement, third-party management, promotional activities, data privacy, speak-up systems, and policy adherence. Our assessments cover both proactive (preventive) and reactive (incident-driven) approaches.

      Yes. We use a structured, defensible methodology that includes risk identification, classification (e.g., likelihood and impact scoring), prioritization, and mitigation planning. Our approach is informed by global best practices and tailored to your internal governance framework.

      Absolutely. We build tailored risk assessment frameworks that align with your organizational structure, compliance maturity, regulatory footprint, and internal risk appetite—whether you’re a startup, mid-size biotech, or global pharma company.

      Yes. We provide risk heatmaps, scoring templates, interview guides, and SharePoint-based tools to streamline data collection, scoring, and documentation. We can also train your teams to use these tools independently.

      Yes. We conduct interactive workshops—onsite or virtual—with key internal stakeholders to gather insights, map current processes, and assess inherent and residual risks across business functions.

      We recommend conducting a baseline risk assessment annually and updating it during major business changes (e.g., launch planning, new partnerships, mergers). We can also set up a cadence for ongoing monitoring or quarterly refresh cycles.

      Yes. We offer targeted assessments for individual markets, departments (e.g., Medical, Commercial, Regulatory), or processes (e.g., advisory boards, grants, patient support programs) based on risk exposure and local regulatory obligations.

      Definitely. We not only identify risks but also help develop practical mitigation strategies, internal controls, CAPA plans, and responsibility matrices to drive accountability and reduce exposure.

      Our assessments are aligned with relevant global and local frameworks such as EFPIA, ABPI, FCPA, UK Bribery Act, EU GDPR, and IFPMA codes. We also stay up to date with guidance issued by enforcement bodies and industry associations.

      Reach out through our Contact Page or email us at hello@eunomiapharmaservices.com. We'll conduct an initial discussion to understand your current state and design a risk assessment strategy that fits your objectives and timeline.

      Book a Consultation